These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15937465)

  • 1. Neutralizing antibodies take a swipe at HIV in vivo.
    Montefiori DC
    Nat Med; 2005 Jun; 11(6):593-4. PubMed ID: 15937465
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunology. Close to the edge: neutralizing the HIV-1 envelope.
    Nabel GJ
    Science; 2005 Jun; 308(5730):1878-9. PubMed ID: 15976295
    [No Abstract]   [Full Text] [Related]  

  • 3. Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.
    Trkola A; Kuster H; Rusert P; Joos B; Fischer M; Leemann C; Manrique A; Huber M; Rehr M; Oxenius A; Weber R; Stiegler G; Vcelar B; Katinger H; Aceto L; Günthard HF
    Nat Med; 2005 Jun; 11(6):615-22. PubMed ID: 15880120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's new in HIV/AIDS? Neutralizing HIV antibodies: do they really protect?
    Jülg B; Goebel FD
    Infection; 2005 Oct; 33(5-6):405-7. PubMed ID: 16258878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immunization for the treatment of HIV infection.
    Jacobson JM
    Mt Sinai J Med; 1998 Jan; 65(1):22-6. PubMed ID: 9458680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines.
    Albert J; Chiodi F; Fenyö EM
    J Intern Med; 2007 Jul; 262(1):2-4. PubMed ID: 17598811
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutralizing antibodies against HIV -- back in the major leagues?
    Ferrantelli F; Ruprecht RM
    Curr Opin Immunol; 2002 Aug; 14(4):495-502. PubMed ID: 12088685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Support for the RV144 HIV vaccine trial.
    Belshe R; Franchini G; Girard MP; Gotch F; Kaleebu P; Marthas ML; McChesney MB; McCullough R; Mhalu F; Salmon-Ceron D; Sekaly RP; van Rompay K; Verrier B; Wahren B; Weissenbacher M
    Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection.
    Stiegler G; Katinger H
    J Antimicrob Chemother; 2003 Apr; 51(4):757-9. PubMed ID: 12654737
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV vaccine development--improving on natural immunity.
    Johnston MI; Fauci AS
    N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447
    [No Abstract]   [Full Text] [Related]  

  • 11. Human monoclonal antibodies for passive immunotherapy of HIV-1.
    Katinger H
    Antibiot Chemother (1971); 1994; 46():25-37. PubMed ID: 7826037
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of neutralizing antibodies in HIV infection.
    Humbert M; Dietrich U
    AIDS Rev; 2006; 8(2):51-9. PubMed ID: 16848273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.
    Füst G
    Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV/AIDS research. Potent HIV antibodies spark vaccine hopes.
    Cohen J
    Science; 2009 Sep; 325(5945):1195. PubMed ID: 19729632
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV/AIDS: allied responses.
    Mascola JR
    Nature; 2007 Sep; 449(7158):29-30. PubMed ID: 17805280
    [No Abstract]   [Full Text] [Related]  

  • 16. Passive immunization for the prevention and treatment of HIV infection.
    Zolla-Pazner S; Gorny MK
    AIDS; 1992 Nov; 6(11):1235-47. PubMed ID: 1472330
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.
    Schoofs T; Klein F; Braunschweig M; Kreider EF; Feldmann A; Nogueira L; Oliveira T; Lorenzi JC; Parrish EH; Learn GH; West AP; Bjorkman PJ; Schlesinger SJ; Seaman MS; Czartoski J; McElrath MJ; Pfeifer N; Hahn BH; Caskey M; Nussenzweig MC
    Science; 2016 May; 352(6288):997-1001. PubMed ID: 27199429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for competition from self during passive immunization, with application to broadly neutralizing antibodies for HIV.
    Ali Tabei SM; Li Y; Weigert M; Dinner AR
    Vaccine; 2012 Jan; 30(3):607-13. PubMed ID: 22119591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo neutralization of HIV-1 quasi-species by a broadly reactive humanized monoclonal antibody KD-247.
    Matsushita S; Takahama S; Shibata J; Kimura T; Shiozaki K; Eda Y; Koito A; Murakami T; Yoshimura K
    Hum Antibodies; 2005; 14(3-4):81-8. PubMed ID: 16720978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the future of HIV vaccines.
    Nabel GJ
    Nat Rev Microbiol; 2007 Jul; 5(7):482-4. PubMed ID: 17571457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.